BMT-CARE: Psychosocial Intervention for Transplant Caregivers
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.
Eligibility criteria
Qualifiers
Adult caregivers (≥18 years) relative or friend of a patient identified as living with them or having in-person contact with them at least twice a week.
Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer.
Ability to read and respond to survey questions in English, Spanish or with minimal assistance from an interpreter.
Disqualifiers
Caregivers of patients undergoing HCT for a benign hematologic condition or undergoing outpatient HCT.
Caregivers with a major untreated psychiatric or cognitive condition which the treating oncology clinicians believes interferes with the capacity to provide informed consent.
Caregivers of patients who have already undergone HCT within the past 5 years
Adult patients (≥18 years) with a hematologic malignancy and planned admission for autologous or allogeneic HCT.
Trial design
Treatments tested in this trial
- BMT-CARE
- Usual Care
Treatment groups
800 Participants
are divided into 2 treatment groupsSponsors and collaborators
Massachusetts General Hospital
Lead sponsor
National Institutes of Health (NIH)
Collaborator
Source ClinicalTrials.gov